Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions

The Parkinson’s disease (PD)-associated kinase Leucine-Rich Repeat Kinase 2 (LRRK2) is a crucial modulator of the autophagy-lysosome pathway, but unclarity exists on the precise mechanics of its role and the direction of this modulation. In particular, LRRK2 is involved in the degradation of patholo...

Descripción completa

Detalles Bibliográficos
Autores principales: Obergasteiger, Julia, Frapporti, Giulia, Lamonaca, Giulia, Pizzi, Sara, Picard, Anne, Lavdas, Alexandros A., Pischedda, Francesca, Piccoli, Giovanni, Hilfiker, Sabine, Lobbestael, Evy, Baekelandt, Veerle, Hicks, Andrew A., Corti, Corrado, Pramstaller, Peter P., Volta, Mattia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280235/
https://www.ncbi.nlm.nih.gov/pubmed/32550012
http://dx.doi.org/10.1038/s41420-020-0279-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280235/
https://www.ncbi.nlm.nih.gov/pubmed/32550012
http://dx.doi.org/10.1038/s41420-020-0279-y

Ejemplares similares